Invasive carcinoma in clinically suspicious breast masses diagnosed as adenocarcinoma by fine-needle aspiration

Cancer

Volumn 90, Issue 2, 2000, Pages 96-101

  Chhieng, David C ^a   Fernandez, Gerardo ^b   Cangiarella, Joan F ^a   Cohen, Jean Marc ^a   Waisman, Jerry ^a   Harris, Matthew N ^a   Roses, Daniel F ^a   Shapiro, Richard L ^a   Symmans, W Fraser ^a,c  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b Hudson Valley Hospital Center   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Biopsy; Breast; Carcinoma; Invasion; Needle

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; BREAST BIOPSY; BREAST CARCINOMA; CANCER GRADING; CANCER INVASION; CANCER RISK; CARCINOMA IN SITU; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MINIMALLY INVASIVE SURGERY; NEEDLE BIOPSY; PRIORITY JOURNAL;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; MIDDLE AGED;

EID: 0034712751     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(20000425)90:2<96::AID-CNCR4>3.0.CO;2-J     Document Type: Article

References (47)

1. Hermansen C, Poutsen HS, Jensen J, Langfeldt B, Steenskov V, Frederiksen P, et al. Diagnostic reliability of combined physical examination, mammography, and fine needle puncture ("triple test") in breast tumors. Cancer 1987;60: 1866-71.
2. Silverman JF, Lanin DR, O'Brien K, Norris HT. The triage role of fine needle aspiration biopsy of palpable breast masses. Diagnostic accuracy and cost effectiveness. Acta Cytol 1987;31:731-6.
3. Wanebo HJ, Feldman PS, Morton C, Wilhelm MC, Covell JL, Binns RL. Fine needle aspiration cytology in lieu of open biopsy in management of primary breast cancer. Ann Surg 1984;199:569-79.
4. Palombini L, Fulciniti F, Vetrani A, De Rosa G, Di Benedetto G, Zeppa P, et al. Fine needle aspiration biopsies of breast masses: a critical analysis of 1956 cases in 8 years (1976-1984). Cancer 1988;61:2273-7.
5. Sneige N. Fine needle aspiration of the breast: a review of 1,995 cases with emphasis on diagnostic pitfalls. Diagn Cytopathol 1993;9:106-12.
6. Frable WJ. Needle aspiration of the breast. Cancer 1984;53: 671-6.
7. Thomas PA, Vazquez MF, Waisman J. Comparison of fine needle aspiration and frozen section of palpable mammary lesions. Mod Pathol 1990;3:570-4.
8. Kurtz JM, Jacquemier K, Torhorst J, Spitalier JM, Amalric R, Hunig R, et al. Conservation therapy for breast cancers other than infiltrating ductal carcinoma. Cancer 1989;63:1630-5.
9. Hortobagyi GN, Ames FC, Buzdar AU, Kay SW, McNeese MD, Paulus D, et al. Management of stage III primary breast cancer with primary chemotherapy, surgery and radiation therapy. Cancer 1988;62:2507-16.
10. Silverman JF, Masood S, Ducatman BS, Wang HH, Sneige N. Can FNA biopsy separate atypical hyperplasia, carcinoma in situ and invasive carcinoma of the breast: cytomorphologic criteria and limitations in diagnosis. Diagn Cytopathol 1993; 9:713-28.
11. Wang HH, Ducatman BS, Eick D. Comparative features of ductal carcinoma in situ and infiltrating ductal carcinoma of the breast on fine needle aspiration biopsy. Am J Clin Pathol 1989;92:736-40.
12. Sneige N, White VA, Katz R, Troncoso P, Libshitz HI, Hortobagyi GN. Ductal carcinoma in situ of the breast: fine needle aspiration cytology of 12 cases. Diagn Cytopathol 1989;5:371-7.
13. Masood S, Frykberg ER, McLellan GL, Dee S, Bullard JB. Cytologic differentiation between proliferative and nonproliferative breast disease in mammographically guided fineneedle aspirates. Diagn Cytopathol 1991;7:581-90.
14. Shin HJ, Sneige N. Is a diagnosis of infiltrating versus in situ ductal carcinoma of the breast possible in fine needle aspiration specimens? Cancer (Cancer Cytopathol) 1998;84:186-91.
15. Shabot MM, Goldberg IM, Schick P, Nieberg R, Pilch YH. Aspiration cytology is superior to Tru-cut needle biopsy in establishing the diagnosis of clinically suspicious breast masses. Ann Surg 1982;96:122-6.
16. Elston CW, Cotton RE, Davies CJ, Blarney RW. A comparison of the use of the 'Tru-Cut' needle and fine needle aspiration cytology in the pre-operative diagnosis of carcinoma of the breast. Histopathology 1978;2:239-54.
17. Oertel YC. Fine needle aspiration of the breast. Stoneham, MA: Butterworths Publishers, 1987.
18. Silverstein MJ, Waisman JR, Gamagami P, Gierson ED, Colburn WJ, Rosser RJ, et al. Intraductal carcinoma of the breast (208 cases): clinical factors influencing treatment choice. Cancer 1990;66:102-8.
19. Barrows GH, Anderson TJ, Lamb JL, Dixon JM. Fine needle aspiration of breast cancer: relationship of clinical factors to cytology results in 689 primary malignancies. Cancer 1986; 58:1493-8.
20. Kern WH. The diagnosis of breast cancer by fine needle aspiration smears. JAMA 1979;241:1125-7.
21. Alderson MR, Hamlin I, Staunton MD. The relative significance of prognostic factors in breast carcinoma. Br J Cancer 1971;25:646-55.
22. Hutter RVP. The influence of pathologic factors on breast cancer management. Cancer 1980;46:961-70.
23. Fisher B, Redmond C, Fisher ER. Ten year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without irradiation. An overview of the randomized trials. N Engl J Med 1989;32:491-6.
24. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and surgery in early breast cancer. N Engl J Med 1995;333:1444-55.
25. Haffty BG, Ward B, Pathare P, Salem R, McKhann C, Beinfield M, et al. Reappraisal of the role of axillary lymph node dissection in the conservative treatment of breast cancer. J Clin Oncol 1997;15:691-700.
26. Lagios MD, Westdahl PR, Margolin FR, Rose MR. Duct carcinoma in situ: relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastatses, and short term treatment failures. Cancer 1982;50:1309-14.
27. Silverstein MJ, Rosser RJ, Gierson ED, Waisman JR, Gamagami P, Hoffman RS, et al. Axillary lymph node dissection for intraductal breast carcinoma - is it indicated? Cancer 1987;59:1819-24.
28. Silverstein MJ, Gierson ED, Colburn WJ, Rosser RJ, Waisman JR, Gamagami P. Axillary lymphadenectomy for intraductal carcinoma of the breast. Surg Gynecol Obstet 1991;172:211-4.
29. Bondeson L, Lindholm K. Prediction of invasiveness by aspiration cytology applied to nonpalpable breast carcinoma and tested in 300 cases. Diagn Cytopathol 1997;17:315-20.
30. Owen AWM, Anderson TJ, Forrest APM. "Closed" biopsy for breast cancer. JR Coll Surg Edinb 1980;25:237-41.
31. Dixon JM, Lamb J, Anderson TJ. Fine needle aspiration of the breast: importance of the aspirator [letter]. Lancet 1983; 2:564.
32. Ballo MS, Sneige N. Can core needle biopsy replace fine needle aspiration cytology in the diagnosis of palpable breast carcinoma: a comparative study of 124 women. Cancer 1996;78:773-7.
33. Jackman RJ, Nowels KW, Shepard MJ, Finkelstein SI, Marzoni FA. Stereotactic large core needle biopsy of 450 nonpalpable breast lesions with surgical correlation in lesions with cancer or atypical hyperplasia. Radiology 1994;193:91-5.
34. Liberman L, Dershaw DD, Rosen PP, Giess CS, Cohen MA, Abramson AF, et al. Stereotactic core biopsy of breast carcinoma: accuracy at predicting invasion. Radiology 1995; 194:379-81.
35. Tavassoli FH. Pathology of the breast. 1st edition. Norwalk, CT: Appleton and Lange, 1992.
36. Lagios MD, Margolin PR, Westdahl PR, Rose MR. Mammographically detected duct carcinoma in situ: frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer 1989;63:618-24.
37. Patchefsky AS, Schwartz GF, Finkelstein SD, Prestipino A, Sohn SE, Singer JS, et al. Heterogeneity of intraductal carcinoma of the breast. Cancer 1989;63:731-41.
38. Fentiman IS, Fagg N, Mills RR, Hayward JL. In situ ductal carcinoma of the breast. Implications of disease pattern and treatment. Eur J Surg Oncol 1986;12:261-6.
39. Kinne DW, Petrek JA, Osborne MP, Fracchia AA, Depalo AA, Rosen PP. Breast carcinoma in situ. Arch Surg 1989;124: 33-6.
40. Schuh ME, Nemoto T, Penetrante RB, Rosner D, Dao TL. Intraductal carcinoma. Analysis of presentation, pathologic findings, and outcome of disease. Arch Surg 1986;121:1303-7.
41. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993;2:335-40.
42. Giuliano AE, Kirgan DM, Guenther JM, Mortom DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-8.
43. O'Hea BJ, Hill AD, El-Shirbiny AM, Yeh SD, Rosen PP, Coit DG, et al. Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg 1998;186:423-7.
44. Rubio IT, Korourian S, Cowan C, Krag DN, Colvert M, Klimberg VS. Sentinel lymph node biopsy for staging breast cancer. Am J Surg 1998;176:532-7.
45. Nwariaku FE, Euhus DM, Beitsch PD, Clifford E, Erdman W, Mathews D, et al. Sentinel lymph node biopsy, an alternative to elective axillary dissection for breast cancer. Am J Surg 1998;176:529-31.
46. Barnwell JM, Arrendondo MA, Kollmorgen D, Gibbs JF, Lamonica D, Carson W, et al. Sentinel node biopsy in breast cancer. Ann Surg Oncol 1998;5:126-30.
47. Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg VS, Shriver C, et al. The sentinel node in breast cancer - a multicenter validation study. N Engl J Med 1998;339:941-6.